FDXACB1 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-90460
Key Product Details
Species Reactivity
Human
Applications
Immunohistochemistry, Immunohistochemistry-Paraffin
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
This antibody was developed against Recombinant Protein corresponding to amino acids: HPIKTINEKLIAELGKVFPLKRLKCSYPLLPQEGTSVLPFWNCDFLSAAFWISLHEDNSNSESLTGGTSQDVEDFLVSFSELSLLKNPGRDGKEEACEGTCG
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for FDXACB1 Antibody
Immunohistochemistry: FDXACB1 Antibody [NBP1-90460]
Immunohistochemistry: FDXACB1 Antibody [NBP1-90460] - Staining of human prostate shows strong cytoplasmic positivity in glandular cells.Applications for FDXACB1 Antibody
Application
Recommended Usage
Immunohistochemistry
1:50 - 1:200
Immunohistochemistry-Paraffin
1:50 - 1:200
Application Notes
For IHC-Paraffin, HIER pH 6 retrieval is recommended.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
PBS (pH 7.2) and 40% Glycerol
Preservative
0.02% Sodium Azide
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: FDXACB1
Alternate Names
ferredoxin-fold anticodon binding domain containing 1, ferredoxin-fold anticodon-binding domain-containing protein 1
Gene Symbol
FDXACB1
Additional FDXACB1 Products
Product Documents for FDXACB1 Antibody
Product Specific Notices for FDXACB1 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...